Clinical Trials Logo

Dyslipidemia clinical trials

View clinical trials related to Dyslipidemia.

Filter by:

NCT ID: NCT03606824 Not yet recruiting - Dyslipidemia Clinical Trials

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD

Start date: August 5, 2018
Phase: N/A
Study type: Interventional

In ASCVD patients complicated with subclinical hypothyroidism, the percentage of those who did not reach the target of lipid-lowering therapy (LDL-C>1.8mmol/L) is usually higher than that in population with normal thyroid function. The present study aims to randomly compare two lipid-lowering therapeutic strategies (statins only vs. statins combined with thyroid hormone supplement).

NCT ID: NCT03527069 Not yet recruiting - Dyslipidemia Clinical Trials

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Cipros 10 association in the treatment of Isolated Hypertriglyceridemia and Dyslipidemia Treatment

NCT ID: NCT03403283 Recruiting - Dyslipidemia Clinical Trials

Dyslipidemia and Diabetic Retinopathy

D&D
Start date: January 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

NCT ID: NCT03401580 Not yet recruiting - Hypertension Clinical Trials

Efficacy of Fixed-doses of Antihypertensive and Statin Drugs

Start date: January 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of different fixed-dose combination of Viena II in treatment of hypertension and dyslipidemia.

NCT ID: NCT03267329 Not yet recruiting - Hypertension Clinical Trials

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Start date: February 2018
Phase: Phase 4
Study type: Interventional

This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.

NCT ID: NCT03235362 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

Start date: August 7, 2017
Phase: Phase 1
Study type: Interventional

This is a phase 1, open label, multiple-dose, crossover clinical trial to investigate the pharmacokinetic drug interaction between YHR1705 and YHR1706 in healty male volunteers

NCT ID: NCT03210649 Completed - Dyslipidemia Clinical Trials

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Start date: March 7, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519

NCT ID: NCT03210532 Completed - Hypertension Clinical Trials

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Start date: October 7, 2016
Phase: Phase 3
Study type: Interventional

A Multicenter, Randomized, Double-blinded, Double-dummy, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Treatment with DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients with Hypertension and Dyslipidemia

NCT ID: NCT03203915 Recruiting - Obesity Clinical Trials

Metabolic Response to Chardonnay Grape Pomace Powder

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

To determine if the addition of chardonnay grape pomace powder enriched with grape seed extract to the diet will result in reducing blood levels of cholesterol or triglycerides.

NCT ID: NCT03191227 Completed - Obesity Clinical Trials

The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort

Mitchelstown
Start date: April 2010
Phase: N/A
Study type: Observational [Patient Registry]

The aim of the Cork and Kerry Study Phase II (Mitchelstown cohort recruited 2010-11) is to provide an updated profile of glucose tolerance status, cardiovascular health and their related factors in an Irish adult general population sample and to compare the findings with those obtained during baseline assessment of Phase I of the Cork and Kerry study (1998) and the rescreen (2008).